This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Systimmune, Inc., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 16 
2 out of 7 
1 out of 2 Years Active: 2023-2026
Title: The Innovative Mind of Yu Liang: Advancements in Protein Engineering
Introduction: Yu Liang, a prominent inventor based in Redmond, WA, has made significant contributions to the field of protein engineering. With a portfolio boasting three patents, Liang's work is at the intersection of biotechnology and therapeutic development, reflecting his commitment to advancing medical science.
Latest Patents: Yu Liang's latest patents showcase groundbreaking innovations in guidance and navigation control proteins and multi-specific antibodies. His patent titled "Guidance and Navigation Control Proteins and Method of Making and Using Thereof" introduces GNC proteins that utilize various binding domains to enhance T cell activation and targeting of tumor-associated antigens. This innovative approach aims to improve immune response against cancer cells by ensuring strategic positioning of binding domains.
Additionally, his patent on "Multi-Specific Antibodies and Methods of Making and Using Thereof" describes a tetra-specific antibody monomer designed to target multiple antigens. This monomer comprises several domains, providing a versatile tool for combating tumor antigens and facilitating immune signaling. The combined capabilities of these antibodies represent a significant leap forward in therapeutic strategies against diseases.
Career Highlights: Throughout his career, Yu Liang has been associated with reputable organizations such as Systimmune, Inc. and Baili-bio (Chengdu) Pharmaceutical Co., Ltd., where he has not only contributed his expertise but also fostered a culture of innovation. His patents are a testament to his dedication to developing advanced solutions in the medical field.
Collaborations: Liang has collaborated with several notable professionals, including Ole Olsen and Dong Xia. These collaborations reflect his commitment to teamwork and highlight the importance of diverse expertise in the advancement of biomolecular research.
Conclusion: As an inventor, Yu Liang continues to push the boundaries of science with his innovative approaches to protein engineering. His impactful patents have the potential to revolutionize therapies in oncology and beyond, making him a notable figure in the realm of biotechnology. With a promising future ahead, Yu Liang exemplifies the spirit of innovation in the quest for medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile